Ozempic and other GLP-1 agonists are helping millions with weight loss but concerns grow over their long-term effects. Recent ...

Recent studies have shed light on these medications’ benefits and potential risks. Ozempic’s common side effects include nausea, diarrhea, constipation, and acid reflux, which are generally mild ...

Maintaining muscle mass is crucial for health, and researchers have identified the protein BCL6 as vital for this. Studies ...

Salk scientists identify protein BCL6 as a key regulator of muscle maintenance in mice; BCL6-enhancing therapies may prevent ...

A brand new candidate for weight-loss treatment is on the table, with scientists uncovering for the first time how a hormone ...

KANSAS CITY — The 2025 Winter Fancy Food Show saw more than 12,000 attendees and over 400 new product exhibits from global ...

DTC Telehealth Platforms - Arrangements involving telemedicine and direct-to-consumer (“DTC”) business services are expected to be a source ...

Echoing Iselin's assessment, Fallon Health CEO Manny Lopes said both providers and payers are at a "crisis point." Meanwhile, WellSense Health Plan President Heather Thiltgen said Massachusetts is ...

Shares of newly public Metsera (NASDAQ:MTSR), which is developing ultra-long-acting obesity drugs, rallied 54% following a ...

Dr. Anna Lembke says that all that convenience and abundance is making us less happy, and there is plenty of research to back her up: In the developed world, we are lonelier, more anxious and more ...

Novo Nordisk (NVO) said its popular diabetes drug Ozempic, also known as semaglutide, has been approved to reduce the risk of kidney disease worsening, kidney failure, and death from cardiovascular ...